Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:2124
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
LETTER TO THE EDITOR  
Year : 2014  |  Volume : 7  |  Issue : 4  |  Page : 216-217
Tumefactive demyelination: A rare presentation of HIV


Department of Neurology, Sawai ManSingh Medical College, Jaipur, Rajasthan, India

Click here for correspondence address and email

Date of Web Publication5-Mar-2015
 

How to cite this article:
Rajendra JS, Rahul H, Kadam N, Swayam P. Tumefactive demyelination: A rare presentation of HIV. Ann Trop Med Public Health 2014;7:216-7

How to cite this URL:
Rajendra JS, Rahul H, Kadam N, Swayam P. Tumefactive demyelination: A rare presentation of HIV. Ann Trop Med Public Health [serial online] 2014 [cited 2019 Sep 18];7:216-7. Available from: http://www.atmph.org/text.asp?2014/7/4/216/152599
Sir,

Tumefactive demyelination is defined as a demyelinating plaque of more than 2 cm in diameter and is considered as intermediate between multiple sclerosis and acute demyelinating encephalomyelitis (ADEM). [1] Although neurological manifestations in human immunodeficiency virus (HIV) infection are common, demyelinating diseases are rarely seen. [2] Not many case reports of tumefactive demyelination in HIV have been published so far. We herein report a previously undiagnosed HIV positive patient presenting with features of tumefactive demyelination as initial manifestation of HIV infection.

A 30-year-old manual laborer presented with two episodes of left partial seizures with secondary generalization followed by progressive left hemiparesis and altered sensorium since 25 days. On examination, the patient was stuporous with motor power Medical Research Council (MRC) grade 0/5 in left upper and lower limbs. Contrast magnetic resonance imaging (MRI) brain showed bilateral, asymmetric, incomplete ring enhancing lesions predominantly involving white matter of right frontoparietal and left frontal lobe with mass effect and midline shift towards left, along with involvement of genu and splenium of corpus callosum, without diffusion weighted restriction [Figure 1] [Figure 2] [Figure 3]. Laboratory investigations with enzyme-linked immunosorbent assay (ELISA) revealed that the patient was HIV positive. We advised a stereotactic biopsy, but patient's relatives refused for any invasive procedure. Thus, based on the contrast MRI features, a diagnosis of tumefactive demyelination was made and the patient was treated with antiretroviral therapy and injectable methylprednisolone followed by tapering dose of oral steroids over 2 months to which he showed significant response and improved.{Figure 1}{Figure 2}{Figure 3}

Radiological hallmarks of tumefactive demyelination are important to be recognized as it may avoid invasive procedure of the brain. Open ring sign, corpus callosum involvement, increased apparent diffusion coefficients within tumefactive demyelinating lesions, and rapid resolution with steroid therapy are MRI features suggestive of tumefactive demyelination. [1] Other possible intracranial space occupying lesion in an HIV positive patient are lymphoma, glioma, toxoplasma infection, and pyogenic abscess. All these conditions were radiologically excluded due to open ring enhancement, increased apparent diffusion coefficients, and improvement with steroids. [3],[4] Although, a stereotactic biopsy to confirm the nature of lesion would have been ideal, but we could not get the tissue diagnosis as the patient's relatives refused for any invasive procedure.

This case highlights the importance of radiological features of tumefactive demyelination especially in an HIV positive patient as tissue diagnosis is difficult in these patients and biopsy result may not be able to differentiate low grade glioma and tumefactive demyelination in many cases, and management is dependent on radiological features.

 
   References Top

1.
Nadkar MY, Deore RA, Singh R. Tumefactive demyelination. J Assoc Physicians India 2008;56:901-3.  Back to cited text no. 1
    
2.
Uriel A, Stow R, Johnson L, Varma A, du Plessis D, Gray F, et al. Tumefactive demyelination - an unusual neurological presentation of HIV. Clin Infect Dis 2010;51:1217-20.  Back to cited text no. 2
    
3.
Kim DS, Na DG, Kim KH, Kim JH, Kim E, Yun BL, et al. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: Added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Radiology 2009;251:467-75.  Back to cited text no. 3
    
4.
Given CA 2nd, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol 2004;182:195-9.  Back to cited text no. 4
    

Top
Correspondence Address:
Handa Rahul
Department of Neurology, Sawai ManSingh Medical College, JLN Marg, Jaipur - 302 004, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.152599

Rights and Permissions


    Figures

  [Figure 1]AnnTropMedPublicHealth_2014_7_4_216_152599_f1.jpg, [Figure 2]AnnTropMedPublicHealth_2014_7_4_216_152599_f2.jpg, [Figure 3]AnnTropMedPublicHealth_2014_7_4_216_152599_f3.jpg



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


    References
    Article Figures

 Article Access Statistics
    Viewed855    
    Printed12    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal